Michael P. Samar - 23 Jun 2023 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Michael P. Samar
Issuer symbol
UBX
Transactions as of
23 Jun 2023
Net transactions value
$0
Form type
4
Filing time
26 Jun 2023, 17:06:28 UTC
Previous filing
26 Jul 2022
Next filing
21 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +6,000 $0.000000 6,000 23 Jun 2023 Common Stock 6,000 $3.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 23, 2023 or (ii) the date of the 2024 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.